Bert L. Chenard

Dr. Chenard is the Head of Chemistry at eXIthera Pharmaceuticals. He serves as the Executive Director of Medicinal Chemistry at Sunovion, bringing over 30 years of industry experience specializing in ion-channel and G-protein coupled receptor (GPCR) research. Previously, Dr. Chenard served as Senior Vice President of Chemistry, Pharmacology, and Preclinical Development at Hydra Biosciences. Prior to Hydra, he was the Senior Vice President of Chemistry and Process Research at Neurogen Corp. Dr. Chenard was a Research Advisor at Pfizer Inc. for over 15 years. Dr. Chenard began his career at DuPont's Experimental Station in exploratory organic chemistry. As a result of his work, Dr. Chenard delivered more than a dozen small-molecule developmental candidates and several specialized reagents. Dr. Chenard received his B.A. at Central Connecticut State University and his Ph.D. from Ohio State University.